The Faculty of Pharmacy of the Universidade de Lisboa (FFUL) will launch the 3rd edition of the International Market Access postgraduate course, which will take place from the 16th of September 2025 up to the 24th of February 2026. This fully online course, taught in English, maintains a strong international focus and will feature global experts in market access.
The program will cover key areas such as HEOR (Health Economics and Outcomes Research), Government Affairs, Pricing, International and national market access, and RWD/RWE (Real-World Data / Real-World Evidence).
Designed for professionals with or without prior experience in the field, this course provides a comprehensive overview of market access processes. It focuses on effective access strategies for drug introduction and reimbursement in major global markets, including Europe (Portugal, Germany, France, Spain, Italy, the United Kingdom, and the Nordic countries), the United States, Brazil, China, the Middle East, and Japan.
With a structured curriculum tailored to industry demands, the postgraduate program includes contributions from key opinion leaders in the pharmaceutical industry, health technology assessment agencies, and specialized consulting firms, offering in-depth, up-to-date industry insights.
Applications are open until 31st August 2025. For more information, please click here.
